Recent Finacing
Recent Raise
Doron Therapeutics is a clinical-stage company developing MOTYS, an intra-articular biologic for symptomatic knee osteoarthritis, advancing from Phase 2 toward Phase 3 with regulatory and clinical execution focus.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Doron Therapeutics.
